Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PKM | P14618 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | HTR6 | P50406 | 5/20 | 0.41 |
| ▸ | VDR | P11473 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | HTR2C | P28335 | 1/20 | 0.32 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.32 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.32 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.32 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.31 |
| ▸ | CASR | P41180 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12913709 | 0.89 | VDR (0.43) | TSHRVDRCYP1A2MAPTMEN1 | |
| SCHEMBL12913705 | 0.85 | VDR (0.45) | TSHRVDRCYP1A2MAPTMEN1 | |
| SCHEMBL12913695 | 0.83 | GAA (0.49) | VDRCYP1A2MAPTMEN1ALDH1A1 | |
| SCHEMBL21160440 | 0.82 | VDR (0.38) | VDRCYP1A2MAPTMEN1ALDH1A1 | |
| SCHEMBL21160443 | 0.77 | KDM4E (0.36) | VDRCYP1A2MAPTMEN1KMT2A | |
| SCHEMBL21160631 | 0.75 | HTR1A (0.41) | TSHRHTR6VDRCYP1A2MAPT | |
| SCHEMBL13203361 | 0.75 | PKM (0.49) | PKMTSHRHTR6MEN1KMT2A | |
| SCHEMBL12913698 | 0.74 | MEN1 (0.52) | VDRCYP1A2MEN1KMT2ACYP1A1 | |
| SCHEMBL21160441 | 0.74 | VDR (0.35) | VDRCYP1A2MAPTMEN1ALDH1A1 | |
| SCHEMBL12913706 | 0.73 | CYP1A2 (0.55) | VDRCYP1A2MAPTMEN1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11215928-B2 | Composition for resist underlayer film formation, resist underlayer film and method for forming the same, and production method of a patterned substrate | JSR CORPORATION (JP) | 2022-01-04 | — | — | US | disclosed |
| US-20190212650-A1 | COMPOSITION FOR RESIST UNDERLAYER FILM FORMATION, RESIST UNDERLAYER FILM AND METHOD FOR FORMING THE SAME, AND PRODUCTION METHOD OF A PATTERNED SUBSTRATE | JSR CORPORATION (JP) | 2019-07-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11215928-B2 | Composition for resist underlayer film formation, resist underlayer film and method for forming the same, and production method of a patterned substrate | TOP1, OXA1L, RER1 | PKM 4013/4885TSHR 3311/4885HTR6 562/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.